Miyuki Mabuchi

发表

Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells In Vivo.

K. Tsujikawa, Yuko Ueda, K. Kitae, 2018, Anticancer research.

Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.

K. Tsujikawa, Yuko Ueda, A. Tanaka, 2015, In vivo.

Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.

K. Tsujikawa, T. Furukawa, S. Aoki, 2014, Bioorganic & medicinal chemistry letters.

Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.

Yi Dai, K. Noguchi, A. Tanaka, 2017, Bioorganic & medicinal chemistry letters.

Identification and purification of target protein using affinity resin bearing a photo-labile linker.

A. Tanaka, Tadashi Shimizu, M. Haramura, 2015, Bioorganic & medicinal chemistry letters.

Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506.

A. Tanaka, Tadashi Shimizu, S. Ikegawa, 2015, Bioorganic & medicinal chemistry letters.

Selective elution of target protein from affinity resins by a simple reductant with a thiol group.

T. Nishizaki, A. Tanaka, Tadashi Shimizu, 2010, Bioorganic & medicinal chemistry letters.

DCP-LA Activates Cytosolic PKCε by Interacting with the Phosphatidylserine Binding/Associating Sites Arg50 and Ile89 in the C2-Like Domain

T. Nishizaki, A. Tanaka, A. Tsuchiya, 2015, Cellular Physiology and Biochemistry.

A Naphthalimide-Based Cd(2+) Fluorescent Probe with Carbamoylmethyl Groups Working as Chelators and PET-Promoters under Neutral Conditions.

Shota Shimabukuro, H. Maeda, K. Tsukamoto, 2016, Chemistry.

Selective degradation of splicing factor CAPERα by anticancer sulfonamides.

T. Owa, Taku Yoshida, Taisuke Uehara, 2017, Nature chemical biology.

Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model.

K. Tsujikawa, Yuko Ueda, A. Tanaka, 2017, Anticancer research.